WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007079182) METHODS FOR TREATING CUTANEOUS LUPUS USING AMINOISOINDOLINE COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2007/079182 International Application No.: PCT/US2006/049490
Publication Date: 12.07.2007 International Filing Date: 28.12.2006
Chapter 2 Demand Filed: 16.07.2007
IPC:
A61K 31/4035 (2006.01) ,A61K 31/454 (2006.01) ,A61P 17/00 (2006.01)
Applicants: ZELDIS, Jerome, B.[US/US]; US (UsOnly)
ROHANE, Patricia, E.W.[US/US]; US (UsOnly)
SCHAFER, Peter, H.[US/US]; US (UsOnly)
CELGENE CORPORATION[US/US]; 86 Morris Avenue Summit, NJ 07901, US (AllExceptUS)
Inventors: ZELDIS, Jerome, B.; US
ROHANE, Patricia, E.W.; US
SCHAFER, Peter, H.; US
Agent: INSOGNA, Anthony, M. ; JONES DAY 222 East 41st Street New York, NY 10017-6702, US
Priority Data:
60/754,79529.12.2005US
60/755,24629.12.2005US
60/787,43630.03.2006US
Title (EN) METHODS FOR TREATING CUTANEOUS LUPUS USING AMINOISOINDOLINE COMPOUNDS
(FR) PROCEDE POUR LE TRAITEMENT DE LUPUS CUTANE METTANT EN OEUVRE DES COMPOSES A BASE D'AMINOISOINDOLINE
Abstract: front page image
(EN) Methods of treating cutaneous lupus in a human are disclosed. Specific methods encompass the administration of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione (ACTIMID™), 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione (REVLIMID®), or cyclopropyl 2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindolin-4-yl} carboxamide, alone or alternatively, in combination with a second active agent.
(FR) La présente invention concerne des procédés de traitement de lupus cutané chez un humain. Des procédés spécifiques comprennent l'administration de (+)-2-[1-(3-éthoxy-4-méthoxyphényl)-2-méthylsulfonyléthyl]-4-acétylaminoisoindoline-1,3-dione, 4-(amino)-2-(2,6-dioxo(3-pipéridyl))-isoindoline-1,3-dione (ACTIMIDE®), 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-pipéridine-2,6-dione (REVLIMIDE®), ou cyclopropyl 2-[(1S)-1-(3-éthoxy-4-méthoxyphényl)-2-(méthylsulfonyl)éthyl]-3-oxoisoindolin-4-yl} carboxamide, seul ou en variante, en combinaison avec un second principe actif.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)